Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
131 JPY | +4.80% | +10.08% | -13.25% |
Business Summary
Number of employees: 22
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Formulation Development and Related Operations
100.0
%
| 59 | 100.0 % | 30 | 100.0 % | -50.35% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
75.6
%
| - | - | 22 | 75.6 % | - |
Japan
24.4
%
| 59 | 100.0 % | 7 | 24.4 % | -87.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 02-01-14 | |
President | 53 | 03-07-31 | |
Ken Fujioka
ADM | Chief Administrative Officer | 56 | 18-10-31 |
Chief Tech/Sci/R&D Officer | 55 | 02-01-14 | |
Hiroshi Akitomo
BRD | Director/Board Member | 63 | 02-05-31 |
Keiko Yamasaki
BRD | Director/Board Member | 74 | 02-01-14 |
Masaru Fukui
AUD | Comptroller/Controller/Auditor | 75 | 08-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 79 | 02-01-14 | |
President | 53 | 03-07-31 | |
Keiko Yamasaki
BRD | Director/Board Member | 74 | 02-01-14 |
Hiroshi Akitomo
BRD | Director/Board Member | 63 | 02-05-31 |
Chief Tech/Sci/R&D Officer | 55 | 02-01-14 | |
Kunio Iwatani
BRD | Director/Board Member | 82 | 16-02-29 |
Ken Fujioka
ADM | Chief Administrative Officer | 56 | 18-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 42,945,100 | 38,981,198 ( 90.77 %) | 2 ( 0.000005 %) | 90.77 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-13.25% | 32.96M | |
+9.85% | 74.45B | |
+11.35% | 9.18B | |
-12.85% | 5.02B | |
+60.16% | 5.03B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.65% | 2.39B | |
+24.62% | 2.26B | |
-27.46% | 2.27B |
- Stock Market
- Equities
- 4586 Stock
- Company MedRx Co., Ltd